Search Results - "Shegai, P V"

Refine Results
  1. 1

    PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy of Prostate Cancer by Tishchenko, V. K., Petriev, V. M., Vlasova, O. P., Krylov, V. V., Shegai, P. V., Ivanov, S. A., Kaprin, A. D.

    Published in Physics of atomic nuclei (01-12-2022)
    “…Molecular changes in prostate cancer lead to increased expression of prostate-specific membrane antigen (PSMA), which is a suitable target for imaging and…”
    Get full text
    Journal Article
  2. 2

    Challenges Faced by Clinicians in the Personalized Treatment Planning: A Literature Review and the First Results of the Russian National Cancer Program by Shegai, P. V., Shatalov, P. A., Zabolotneva, A. A., Falaleeva, N. A., Ivanov, S. A., Kaprin, A. D.

    Published in Critical care research and practice (23-09-2021)
    “…Advances in cancer molecular profiling have enabled the development of more effective approaches to the diagnosis and personalized treatment of tumors…”
    Get full text
    Journal Article
  3. 3

    Preclinical Study of Therapeutic Efficacy of a New Russian Radiopharmaceutical 177Lu-DOTA-PSMA by Tishchenko, V. K., Vlasova, O. P., Lebedeva, A. A., Fedorova, A. V., Pankratov, A. A., Morozova, N. B., Kuzenkova, K. A., Stepchenkova, E. D., Shegai, P. V., Ivanov, S. A., Kaprin, A. D.

    “…The therapeutic efficacy of a Russian radiopharmaceutical 177 Lu-DOTA-PSMA was studied in vivo using male BALB/c nu/nu (nude) mice with prostate carcinoma…”
    Get full text
    Journal Article
  4. 4

    Cytostatic Activity of Combretastatin A-4 Derivatives in an In Vitro System by Plyutinskaya, A. D., Nemtsova, E. R., Pankratov, A. A., Shegai, P. V., Krylov, S. S., Iskandarova, V. N., Maksimenko, A. S., Demchuk, D. V., Kuptsova, T. S., Semenova, M. N., Semenov, V. V.

    “…Cytostatic activity of combretastatin A-4, its 11 analogues, and paclitaxel (Taxacad) was evaluated in vitro on human tumor cells A549 (lung adenocarcinoma)…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Evaluation of the Association of rs4680 COMT Polymorphism and Clinical Parameters of the Tumor in Colorectal Cancer (a Pilot Study) by Ivanova, T. I., Potapov, A. L., Zemskova, D. V., Khorokhorina, V. A., Shegai, P. V., Ivanov, S. A., Kaprin, A. D.

    “…We analyzed association of rs4680 polymorphism of catechol-O-methyltransferase ( COMT ) gene with clinical parameters of the tumor in patients with colorectal…”
    Get full text
    Journal Article
  7. 7

    Prospects for the Application of Methods of Evolutionary Biology in Oncology by Potievskii, M. B., Shegai, P. V., Kaprin, A. D.

    “…Oncological diseases is the second leading cause of death among noninfectious diseases in Russia and worldwide. Evolutionary medicine is a relatively new…”
    Get full text
    Journal Article
  8. 8

    Biodistribution of 213Bi–Metallothionein and 213Bi–IgG in Intact Mice by Petriev, V. M., Tishchenko, V. K., Shegai, P. V., Ivanov, S. A., Kaprin, A. D.

    Published in Physics of atomic nuclei (01-12-2022)
    “…One of the important problems of radiopharmaceutics is the development of new approaches for the creation of radiopharmaceuticals based on antibodies while…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Experimental Study of 99mTc-Metallothionein Biodistribution in Intact Animals by Tishchenko, V. K., Lebedeva, A. A., Fedorova, A. V., Orlenko, S. P., Minaeva, N. G., Shegai, P. V., Ivanov, S. A., Kaprin, A. D.

    Published in Physics of atomic nuclei (01-12-2023)
    “…Metallothioneins are a special group of low-molecular-weight proteins with metal-binding properties, which make them promising chelators for the development of…”
    Get full text
    Journal Article
  11. 11

    Experience of cytokine therapy in the treatment of recurrent cervical cancer by Bykova, E. A., Falaleeva, N. A., Myalina, S. A., Shegai, P. V., Grivtsova, L. Yu

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-01-2024)
    “…Cervical cancer is the most common malignant tumor of the female genital organs. In general, the prognosis in patients with advanced cervical cancer is…”
    Get full text
    Journal Article
  12. 12

    Pharmacokinetic Properties of 99mTc-PSMA: A New Radiopharmaceutical for SPECT Imaging of Prostate Cancer by Tishchenko, V. K., Vlasova, O. P., Ivannikov, A. I., Dorovatovskiy, S. A., Pankratov, A. A., Morozova, N. B., Fedorova, A. V., Lebedeva, A. A., Kuzenkova, K. A., Stepchenkova, E. D., Khailov, A. M., Shegai, P. V., Ivanov, S. A., Kaprin, A. D.

    Published in Physics of atomic nuclei (01-12-2023)
    “…Prostate-specific membrane antigen (PSMA), which is overexpressed in advanced prostate cancer, is a well-established target for the development of antitumor…”
    Get full text
    Journal Article
  13. 13

    Antioxidant Properties of a Nanostructured Clathrate Complex Selenopyran with β-Cyclodextrin in Model Systems of Oxidative Stress by Dzikovskaya, L. A., Degtyareva, E. S., Shegai, P. V., Ivanov, S. A., Kaprin, A. D.

    “…We studied the effect of nanostructured clathrate complex 9-phenyl-symm-octahydoselenoxanthene (selenopyran) with β-cyclodextrin on the generation of ОН·…”
    Get full text
    Journal Article
  14. 14

    Comparative Analysis of Methods of Passive and Active Field Formation in Radiation Therapy With Carbon Ions by AN, Solovev, Gulidov, I A, Soldatov, A P, Shegai, P V, Ivanov, S A, Sergunova, K A, Kaprin, A D

    Published in Nanotechnologies in Russia (01-08-2023)
    “…Comparative data on the irradiation of patients with cancer with beams of carbon ions using passive field-modification methods and an active method of dose…”
    Get full text
    Journal Article
  15. 15

    Biodistribution of 68Ga-NODA-Aminoglucose in Intact and Tumor-Bearing Mice by Tishchenko, V. K., Petriev, V. M., Mikhailovskaya, A. A., Shegai, P. V., Ivanov, S. A., Kaprin, A. D.

    “…We studied the biodistribution of 68 Ga-NODA-aminoglucose ( 68 Ga-NODA-AG) in normal mice and mice with experimental model of colon adenocarcinoma tumor. It…”
    Get full text
    Journal Article
  16. 16

    Analysis of years of life lost due to premature cancer mortality in the Russian Federation by Khailova, Zh. V., Kaprin, A. D., Omelyanovsky, V. V., Pustovalov, D. N., Agafonova, Yu. A., Kusakina, V. O., Ivanov, S. A., Shegai, P. V.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (14-11-2023)
    “…Background. Burden of disease estimation allows analyses to be carried out integrally, including cause and effect assessment. the rate of life years lost due…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Oncology during the New Coronavirus Infection Pandemic by Kaprin, A. D., Sergeeva, N. S., Shegai, P. V., Alekseev, B. Ya

    “…The COVID-19 pandemic has served as a catalyst for a whole layer of scientific research, including in Russia, where, since 2020, international multicenter…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Dose Field Shaping and Biological Effectiveness of the Effect of Pulsed Electron Accelerator Novac-11 on Mammalian Cells by Koryakina, E. V., Lychagin, A. A., Potetnya, V. I., Troshinа, M. V., Saburov, V. O., Moiseev, A. S., Koryakin, S. N., Ivanov, S. A., Shegai, P. V., Kaprin, A. D.

    “…The development of technologies for using the Novac-11 pulsed electron accelerator in radiation therapy of animals with spontaneous neoplasms requires…”
    Get full text
    Journal Article